drug

zalifrelimab

1 story · latest Aug 11, 2026

Status: Investigational
Code: AGEN1884
Trials: 1 registered trial in coverage

Relationships

Developed by Agenus Inc.

Timeline

Agenus posts results for zalifrelimab plus balstilimab trial in advanced cervical cancer

Aug 11Trial updateAgenus Inc.balstilimab

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.